AdVance™ XP

Male Sling System

Established outcomes

  • More than 10 years of clinical use.1
  • More than 30,000 patients treated.1
  • Demonstrated cured and improved rates ranging from 63.1% - 83.0% at 5 years in patients with mild to moderate incontinence. 2.3
  • In patients with higher BMIs, AdVance XP sling has higher cure and improved rates over AdVance Sling.4
  • More than 65 articles published (on AdVance and AdVance XP) in scientific, peer-reviewed journals, reporting on the experience in more than 5,000 patients.1
  • No erosions or explantations of either a whole sling system or fragments of the sling were described throughout the (5 year) follow-up period.3
  • Chronic urinary retention after AdVance Sling placement is uncommon and acute retention is generally self‐limiting.5
  • ICIQ score improved from 14.9 at baseline to 5.0 at 5 years. IQoL improved from 67.3 at baseline to 96.8 at 5 years.3

Patient benefits

  • Minimally invasive procedure designed to allow most patients to resume normal, daily activities 1 -2 weeks post procedure*
  • Patients may be continent immediately following their procedure6
  • Patient manual dexterity and mental acuity are not criteria for exclusion6
  • Can be used in combination with inflatable penile prosthesis7
  • If needed, the transition from an AdVance Sling to an AMS 800™ Artificial Urinary Sphincter does not usually require mesh excision8
  • The Advance XP displays excellent continence results and secure effectiveness over a 5-year period.3 Data also demonstrated a low complication rate and improved quality of life in the long-term use of AdVance XP.3

*per physician's discretion

Top